Overall, our data show significant upregulation (approximately 23-fold higher) of PARP-1 expression in the cancer cell lines compared with human lymphocytes from healthy volunteers and cancer patients (Zaremba et al, 2008). The gene discussed is PARP1; the disease is cancer.